Hepatitis B hyperimmune globulin clinical trials
Also written HBIG.
Includes 2 studies of BT088 immunoglobulin, human.
How each study uses hepatitis B hyperimmune globulin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the hepatitis B hyperimmune globulin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 23 Sept 1977 · Bayhep B, Hyperhep B S/D · BLA 101146 (FDA, Purple Book)
- European Union
- 30 Nov 2009 · Zutectra · EMEA/H/C/001089 (EMA; as BT088 immunoglobulin, human)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2019 | 1 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 7
Biotest Pharmaceuticals Corporation (1) · GlaxoSmithKline (1) · Instituto Grifols, S.A. (1) · Georgetown University (1) · SK Chemicals Co., Ltd. (1) · Biotest (1) · Xi'an Jiaotong University (1) · Cangene Corporation (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test hepatitis B hyperimmune globulin.
- Aug 2027Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV DonorsPhase 4 · University Health Network, Toronto
Studies
Open first, then newest update. How each study uses hepatitis B hyperimmune globulin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 13
- Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis BRecruitingEarly Phase 1Peking University People's HospitalNCT07328711Written as Hepatitis B Immunoglobulin (HBIg)
- Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV DonorsRecruitingPhase 4University Health Network, TorontoNCT07189377Written as HBIG
- Treatment of Patients With Chronic Hepatitis B With Hepatitis B ImmunoglobulinsTerminatedPhase 2Hannover Medical SchoolNCT05345990Written as Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®)
- Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis BWithdrawnPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT03575208Written as hepatitis B immune globulin (HBIg)
- Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver TransplantationCompletedPhase 1/2Biotest Pharmaceuticals CorporationNCT01421212Written as Hepatitis B Immune Globulin (Boca HBVIg)
- LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ MothersCompletedPhase 4GlaxoSmithKlineNCT00240526Written as Hepatitis B immunoglobulin (HBIg)
- Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant RecipientsCompletedPhase 3Instituto Grifols, S.A.NCT01131065Written as Hepatitis B immune globulin
- Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant PatientsCompletedPhase 4Georgetown UniversityNCT00998426Written as HepaGam B (Hepatitis B Immune Globulin (HBIG))
- A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation RecipientsCompletedPhase 3SK Chemicals Co., Ltd.NCT01513850Written as Hepabulin IV
- A Clinical Trial of Zutectra in Patients Who Recently Received a Liver TransplantCompletedPhase 3BiotestNCT01856413Written as Zutectra
- Prevention for Mother-to-infant Transmission of HBVCompletedNot applicableXi'an Jiaotong UniversityNCT02312531Written as Hepatitis B immunoglobulin
- Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant PatientsCompletedPhase 4Cangene CorporationNCT00722332Written as HepaGam B
- Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ MothersCompletedNot applicableGovind Ballabh Pant HospitalNCT01412567Written as Vaccine+HBIG
Given beside what is tested · 1 — hepatitis B hyperimmune globulin is usual care or a partner of the new treatment
Codes
What other systems call hepatitis B hyperimmune globulin · ClinicalTrials.gg INT003207
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C045213 | hepatitis B hyperimmune globulin | One source NLM |
| RxNorm | 26744 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.